Bogomolets National Medical University (NMU) is a medical school founded in 1841 in Kyiv, Russian Empire by the Russian Tsar Nicolas I. The university is named after physiologist Alexander A. Bogomolets. NMU provides medical training for over 10,000 students, including about 1,300 foreigners from 56 countries.[citation needed] The university employs about 1,200 teaching staff.Bogomolets National Medical University is one of the best medical universities in Ukraine. The degree of the university is recognized by the world's most credible organizations like WHO, UNESCO, MCI. It offers various courses in undergraduate and post-graduate levels to students. The university consists of 10 faculties. Bogomolets National Medical University also has a separate Institute for Post Graduate Education. The university is a pioneer in training medical specialists and research personnel in the field of healthcare. Bogomolets National Medical University has around 1500 professors. Included in the numbers are 855 Phd and 205 Doctors of Sciences. Thus, the students are trained by expert professionals and academicians in the field of medicine.
Rationale: To evaluate bone mineral density (BMD) in young adults with inflammatory arthritis. Main result: Low BMD was detected in 42
High-quality care in obstetrics and gynecology (OBGYN) is closely linked to patient satisfaction. However, disparities in care delivery based on patient demographics, including gender, race, and ethnicity, have been documented in the literature. As healthcare institutions strive to improve the quality of care provided to their patients, diversity among gynaecologists is emerging as essential to achieving this goal. Increasing diversity among gynaecologists can lead to better representation of diverse patient populations and improved patient-physician concordance, resulting in higher patient satisfaction. Available evidence shows that there are high levels of disparity in workforce in the field of OBGYN. An example can be provided with women in the United States who make up about 57
Despite advances in pharmacotherapy, many patients with inflammatory arthritis (IA) experience residual pain even in remission. Digital health applications (DHAs), when combined with machine learning, may help identify predictors of pain relief in real-world care. To identify predictors of clinically meaningful pain relief in IA using DHA data. We retrospectively analyzed 914 adults with rheumatoid arthritis, psoriatic arthritis, or spondyloarthritis using the Mida Rheuma App. Patients were categorized according to sufficient pain relief, defined as ≥ 30
The article explores the theoretical, methodological, and applied principles of formation and implementation of state policy to ensure the financial sustainability of the health care system in indeterminate conditions. The relevance of the topic is determined by the fact that the health care system functions under the influence of a consistent layering of pandemic, military, macroeconomic, and technological shocks, which requires rethinking approaches to state financing, budget response, and managerial adaptability. The purpose of the study is to develop a theoretical and methodological basis and applied tools for assessing the financial sustainability of the health care system and developing proposals for improving state policy in this area. As a result, an integral index of the financial sustainability of the healthcare system was constructed, the impact of macroeconomic and crisis factors on its dynamics was assessed, and basic, stressed, and adaptive scenarios for our country for 2026–2030 were formed. It was proven that the sustainability of the healthcare system is determined not only by the scale of public spending, but also by the structure of funding sources, the level of direct financial burden on the population, the stability of the healthcare budget priority, and the ability of the state to implement technologies based on artificial intelligence in the management of financial flows. The practical value of the work lies in the possibility of using its results by state authorities to improve budget policy, develop a program of medical guarantees, and form adaptive mechanisms to ensure the financial sustainability of the healthcare system.
BACKGROUND:Oral and ocular medications are frequently used in the treatment of allergic rhinitis (AR). As part of the update of the Allergic Rhinitis and its Impact on Asthma (ARIA)-EAACI guidelines, this manuscript presents the ARIA-EAACI 2024-2025 recommendations for oral and ocular treatments. METHODS:The ARIA-EAACI 2024-2025 guideline panel issued recommendations following the Grading of Recommendations, Assessment, Development and Evaluation (GRADE) evidence-to-decision framework. Several sources of evidence were used to inform panel judgements and recommendations, including systematic reviews, mHealth and pharmacovigilance data as well as a survey on costs. RESULTS:Eight guideline questions concerning oral treatments for AR and three questions concerning ocular treatments were addressed. These questions led to the recommendations. Overall, these questions concern the choice between different classes of medication. They also discuss the role of oral antihistamines (OAH), leukotriene receptor antagonists (LTRA), ocular antihistamines (OcAH) and ocular mast cell stabilisers. Four questions had not been previously evaluated in ARIA guidelines, while, for the other four, there was a change in the strength or directionality of the recommendations. Overall, these guidelines recommend using intranasal corticosteroids over OAH and using OAH over LTRA. Moreover, they suggest using OAH over OcAH and suggest being against adding LTRA to OAH. Finally, considerations for choosing between different individual OAHs are presented. CONCLUSION:This ARIA-EAACI 2024-2025 article supports patients, their caregivers and healthcare professionals in choosing oral and ocular treatments for AR. Decisions on treatment should consider the clinical variability of the disease, patients' values and the affordability of medications.
